PUBLISHER: Market Research Future | PRODUCT CODE: 1607750
PUBLISHER: Market Research Future | PRODUCT CODE: 1607750
Global Metered Dose Inhalers Market Research Report Information By Product, By Propellant Type, By Technology, By Indication, By Distribution Channel And By Region Forecast Till 2032
Global Metered Dose Inhalers Market Research Report Information By Product (Press Metered Dose Inhalers, Breath Actuated Metered Dose Inhalers), By Propellant Type (HFA 134A, HFA 227EA, HFA 152A), By Technology (Pulmonary Platform Technologies, Nasal Platform Technologies), By Indication (Asthma, COPD, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) Forecast Till 2032
Market Overview
In 2023, the Metered Dose Inhalers Market was estimated to be worth USD 15.8 billion. Over the forecast period (2024-2032), the industry is anticipated to expand from USD 17.1 billion in 2024 to USD 30.0 billion by 2032, with a compound annual growth rate (CAGR) of 6.43%. The global metered-dose inhaler market is experiencing development due to the increasing prevalence of respiratory diseases, the launch of new products by market players, and the increasing awareness and education of the public.
The global MDI market is experiencing significant growth due to the increasing availability of new metered dose inhaler (MDI) products. The technological advancements that these launches bring about, such as improved drug delivery systems and ergonomic designs, are tailored to the preferences of patients for simplicity of use and adherence. Innovative formulations and combinations provide additional therapeutic options for a diverse array of respiratory conditions, thereby enhancing the efficacy of treatment and the quality of patient outcomes.
Market segment insights
The Metered Dose Inhalers Market has been segmented into Press Metered Dose Inhalers and Breath actuated Metered Dose Inhalers based on product.
The Metered Dose Inhalers Market has been segmented into HFA 134a, HFA 227ea, and HFA-152a based on propellant type.
The Metered Dose Inhalers Market has been segmented into pulmonary platform technologies and nasal platform technologies based on technology.
Metered Dose Inhalers Market has been segmented into Asthma, COPD, and other categories based on indication.
Hospital pharmacies, retail pharmacies, and online pharmacies comprise the Metered Dose Inhalers Market, contingent upon their distribution channels.
Regional Perspectives
In 2023, the market share that North America possessed was the most significant. Nevertheless, Asia-Pacific is anticipated to experience the most significant compound annual growth rate (CAGR) during the 2024-2032 forecast period.
The Metered Dose Inhalers market in North America is distinguished by a supportive regulatory environment, technological advancements, and increased healthcare requirements, all of which are driving robust growth. Additionally, the market is driven by the development of state-of-the-art Metered Dose Inhalers, which is made possible by a substantial investment in research and development and a sophisticated healthcare infrastructure.
Europe, which is further divided into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe, follows the Americas region. The Metered Dose Inhalers market in Europe is characterized by a well-established healthcare infrastructure and an increase in healthcare expenditure.
Over the forecast period, the Asia-Pacific region is anticipated to experience robust development, which is driven by a variety of key factors. It is also projected to be the fastest-growing region. The demand for sophisticated inhalers is being driven by the rapid expansion of healthcare infrastructure and the increasing investments in healthcare infrastructure in countries such as China, India, and Japan.
Major Players
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
- 2.1 DEFINITION
- 2.2 SCOPE OF THE STUDY
- 2.3 RESEARCH OBJECTIVE
- 2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
- 3.1 OVERVIEW
- 3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
4 MARKET DYNAMICS
5 MARKET FACTOR ANALYSIS
6 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT
7 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE
8 GLOBAL METERED DOSE INHALERS MARKET, BY TECHNOLOGY
9 GLOBAL METERED DOSE INHALERS MARKET, BY INDICATION
10 GLOBAL METERED DOSE INHALERS MARKET, BY DISTRIBUTION CHANNEL
11 GLOBAL METERED DOSE INHALER MARKET, BY REGION
12 COMPETITIVE LANDSCAPE
13 COMPANY PROFILES
LIST OF TABLES
- TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
- TABLE 2 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
- TABLE 3 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT, 2019-2032 (UNITS)
- TABLE 4 GLOBAL METERED DOSE INHALERS MARKET, FOR PRESS METERED DOSE INHALERS, BY REGION, 2019-2032 (USD MILLION)
- TABLE 5 GLOBAL METERED DOSE INHALERS MARKET, FOR PRESS METERED DOSE INHALERS, BY REGION, 2019-2032 (UNITS)
- TABLE 6 GLOBAL METERED DOSE INHALERS MARKET, FOR BREATH ACTUATED METERED DOSE INHALERS, BY REGION, 2019-2032 (USD MILLION)
- TABLE 7 GLOBAL METERED DOSE INHALERS MARKET, FOR BREATH ACTUATED METERED DOSE INHALERS, BY REGION, 2019-2032 (UNITS)
- TABLE 8 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE, 2019-2032 (USD MILLION)
- TABLE 9 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE, 2019-2032 (UNITS)
- TABLE 10 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 134A, BY REGION, 2019-2032 (USD MILLION)
- TABLE 11 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 134A, BY REGION, 2019-2032 (UNITS)
- TABLE 12 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 227EA, BY REGION, 2019-2032 (USD MILLION)
LIST OF FIGURES
